Company / Assets per Share
Ultragenyx Pharmaceutical Inc. Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$16.56
FY2025
5-year range
$16.56 / $22.78
FY2021-FY2025
Trend
-9.3%
vs FY2024
Sector context
#65 of 210
Health Care
What the data says
At $16.56, Ultragenyx Pharmaceutical Inc.'s assets per share ranks #65 of 210 in the Health Care sector. Assets per Share has declined for 5 consecutive years, from $30.42 in FY2020 to $16.56 in FY2025.
Based on SEC 10-K filings.
16.56 in FY2025 with a 5-year CAGR of -11.5%.
Declined from $21.24 to $16.56 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -9.4%
- 5-Year CAGR
- -11.5%
- 10-Year CAGR
- -
Sector benchmark
#65 of 210 in Health CareTop 31% of 210This company $16.56 Sector average $353.15
▼
-95.3% below sector average
Key checks
Key Insights
- Ultragenyx Pharmaceutical Inc.'s assets per share has declined for 5 consecutive years.
- In FY2025, assets per share decreased 9.3% year-over-year.
- Ranks #65 out of 210 companies in the Health Care sector.
- Peak assets per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -2.91 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $16.56 | -9.3% |
| FY2024 | $18.26 | -14.0% |
| FY2023 | $21.24 | -4.7% |
| FY2022 | $22.29 | -2.2% |
| FY2021 | $22.78 | -25.1% |
| FY2020 | $30.42 | +36.3% |
| FY2019 | $22.33 | +37.0% |
| FY2018 | $16.29 | +36.9% |
| FY2017 | $11.90 | -14.4% |
| FY2016 | $13.90 | -8.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026